Metformin Treatment Is Associated with a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study

<div>(a) Cumulative hazard of NPDR: comparison between metformin users and nonusers with DM. (b) Cumulative hazard of NPDR: comparison between metformin alone users and metformin + DPP-4i users with DM.</div>

Journal of Diabetes Research

fig2

Figure 2

Figure 2: Metformin Treatment Is Associated with a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study 

Figure 2 | Metformin Treatment Is Associated with a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study 